The Supreme Court allowed women to continue to access the abortion pill mifepristone through telehealth visits, imposing a pause on a May 1 decision from the 5th US Circuit Court of Appeals that abruptly required women to obtain the drug through in-person visits.

The Supreme Court allowed women to continue to access the abortion pill mifepristone through telehealth visits, imposing a pause on a May 1 decision from the 5th US Circuit Court of Appeals that abruptly required women to obtain the drug through in-person visits.

Go to News Site